A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.
A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.
AAP NYC architecture faculty Dana Getman and Steven Garcia and students in their fall studio not only asked how to keep pace with New York City's need for more affordable housing but also how to better the lives of people who live in the homes they design and the future they build.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
Weill Cornell Medicine and colleagues in Tanzania are fostering a new generation of M.D./Ph.D. researchers, with implications for improved health care outcomes worldwide.
Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches.
The newest episode of “Startup Cornell,” a podcast hosted by Entrepreneurship at Cornell, features Josh Gully ’83, managing director of NewEdge Wealth.